Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

Comprehensive genomic profiling with subsequent molecularly guided therapy improves outcomes over platinum-based chemotherapy in previously untreated, unfavourable CUP
Дата публикации: 22-09-2026 07:09:00

Updated results after additional follow-up in the CUPISCO study

Основное содержимое страницы с новостью.

Subscribe to ESMO newsletter

Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH

© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Perioperative durvalumab plus FLOT improves OS in patients with resectable gastric or GEJ adenocarcinoma09.2215-09-2026
2Checkpoint Inhibitors Plus Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors04.5701-09-2023
3Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy011.1601-06-2024
4ESMO launches Clinical Trials Funding initiative to optimise cancer care pathways06.3210-09-2026
5Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients with Advanced NSCLC with EGFR Exon 20 Insertions0523-06-2026
6Neoadjuvant Serplulimab with S-1 Plus Oxaliplatin Followed by Adjuvant Serplulimab Significantly Improves EFS in PD-L1-positive, Resectable Gastric or GEJ Adenocarcinoma5730-06-2026
7Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors0725-06-2026
8Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma013.2228-11-2023
9Precision therapy for metastatic prostate cancer improves survival2720-08-2024
10Daraxonrasib shows antitumour activity in patients with previously treated metastatic RAS-mutated NSCLC015.8810-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 16.41. Источник: www.esmo.org.